Erwin Tomasich
- Cancer Research top 10%
-
- Cancer Immunotherapy and Biomarkers 10
- PARP inhibition in cancer therapy 3
-
- Epigenetics and DNA Methylation 8
- Cancer-related gene regulation 4
- RNA modifications and cancer 3
-
- Brain Metastases and Treatment 4
-
- Immunotherapy and Immune Responses 3
-
- Glioma Diagnosis and Treatment 3
Erwin Tomasich
29 papers receiving 544 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 187
- Oncology 179
- Molecular Biology 336
- Pulmonary and Respiratory Medicine 120
- Immunology 72
Countries citing papers authored by Erwin Tomasich
This map shows the geographic impact of Erwin Tomasich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Tomasich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Tomasich more than expected).
Fields of papers citing papers by Erwin Tomasich
This network shows the impact of papers produced by Erwin Tomasich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Tomasich. The network helps show where Erwin Tomasich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erwin Tomasich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 11 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 5 | |
| 13 | 2022 | 10 | |
| 14 | 2022 | 19 | |
| 15 | 2020 | 39 | |
| 16 | 2020 | 10 | |
| 17 | 2017 | 106 | |
| 18 | 2015 | 24 | |
| 19 | 2014 | 72 | |
| 20 | 2014 | 47 |
About Erwin Tomasich
Erwin Tomasich is a scholar working on Oncology, Cancer Research and Immunology, having authored 31 papers that have together received 547 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Epigenetics and DNA Methylation (8 papers), Brain Metastases and Treatment (4 papers), Cancer-related gene regulation (4 papers), Glioma Diagnosis and Treatment (3 papers), RNA modifications and cancer (3 papers), Immunotherapy and Immune Responses (3 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Cancer Research (187 citations), Oncology (179 citations) and Molecular Biology (336 citations). Erwin Tomasich has collaborated with scholars based in Austria, Germany and Hungary. Frequent co-authors include Maximilian Marhold, Gerwin Heller, Michael Krainer, Peter Horak, Reinhard Horvat, Leonhard Müllauer, Barbara Ziegler, Sabine Zöchbauer‐Müller, Christoph Minichsdorfer and Andreas Spittler. Their work appears in journals such as Clinical Cancer Research, Scientific Reports, Translational research, Annals of Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.